| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Parsey Merdad is a Chief Medical Officer at GILD, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 19 sales. Those positions are worth an estimated $11.8M at current prices.
Our model assigns Parsey Merdad a middling insider score of 52/100, based on 13 past trades. Over a 12-month horizon, 30.8% of those trades were profitable, with an average 12-month return of -25.8%.
Parsey Merdad's largest disclosed position is in GILD as Chief Medical Officer, worth about $11.4M. The recent filings there lean toward selling, a net 250,108 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 12,984 | $79.96 | $1,038,225.31 | -15.6% | -4.1% | -9.4% | |
| Dec 30, 2022 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 553 | $85.33 | $47,187.49 | -1.2% | -5.1% | -5.6% | |
| Aug 17, 2020 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 182 | $68.32 | $12,434.24 | -100% | - | - |